Tags

Type your tag names separated by a space and hit enter

Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge.
PLoS Negl Trop Dis. 2013; 7(7):e2330.PN

Abstract

Dengue is the most prevalent arboviral infection, affecting millions of people every year. Attempts to control such infection are being made, and the development of a vaccine is a World Health Organization priority. Among the proteins being tested as vaccine candidates in preclinical settings is the non-structural protein 1 (NS1). In the present study, we tested the immune responses generated by targeting the NS1 protein to two different dendritic cell populations. Dendritic cells (DCs) are important antigen presenting cells, and targeting proteins to maturing DCs has proved to be an efficient means of immunization. Antigen targeting is accomplished by the use of a monoclonal antibody (mAb) directed against a DC cell surface receptor fused to the protein of interest. We used two mAbs (αDEC205 and αDCIR2) to target two distinct DC populations, expressing either DEC205 or DCIR2 endocytic receptors, respectively, in mice. The fusion mAbs were successfully produced, bound to their respective receptors, and were used to immunize BALB/c mice in the presence of polyriboinosinic: polyribocytidylic acid (poly (I:C)), as a DC maturation stimulus. We observed induction of strong anti-NS1 antibody responses and similar antigen binding affinity irrespectively of the DC population targeted. Nevertheless, the IgG1/IgG2a ratios were different between mouse groups immunized with αDEC-NS1 and αDCIR2-NS1 mAbs. When we tested the induction of cellular immune responses, the number of IFN-γ producing cells was higher in αDEC-NS1 immunized animals. In addition, mice immunized with the αDEC-NS1 mAb were significantly protected from a lethal intracranial challenge with the DENV2 NGC strain when compared to mice immunized with αDCIR2-NS1 mAb. Protection was partially mediated by CD4(+) and CD8(+) T cells as depletion of these populations reduced both survival and morbidity signs. We conclude that targeting the NS1 protein to the DEC205(+) DC population with poly (I:C) opens perspectives for dengue vaccine development.

Authors+Show Affiliations

Laboratory of Antigen Targeting to Dendritic Cells, Department of Parasitology, University of São Paulo, São Paulo, Brazil.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

23875054

Citation

Henriques, Hugo R., et al. "Targeting the Non-structural Protein 1 From Dengue Virus to a Dendritic Cell Population Confers Protective Immunity to Lethal Virus Challenge." PLoS Neglected Tropical Diseases, vol. 7, no. 7, 2013, pp. e2330.
Henriques HR, Rampazo EV, Gonçalves AJ, et al. Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge. PLoS Negl Trop Dis. 2013;7(7):e2330.
Henriques, H. R., Rampazo, E. V., Gonçalves, A. J., Vicentin, E. C., Amorim, J. H., Panatieri, R. H., Amorim, K. N., Yamamoto, M. M., Ferreira, L. C., Alves, A. M., & Boscardin, S. B. (2013). Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge. PLoS Neglected Tropical Diseases, 7(7), e2330. https://doi.org/10.1371/journal.pntd.0002330
Henriques HR, et al. Targeting the Non-structural Protein 1 From Dengue Virus to a Dendritic Cell Population Confers Protective Immunity to Lethal Virus Challenge. PLoS Negl Trop Dis. 2013;7(7):e2330. PubMed PMID: 23875054.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge. AU - Henriques,Hugo R, AU - Rampazo,Eline V, AU - Gonçalves,Antonio J S, AU - Vicentin,Elaine C M, AU - Amorim,Jaime H, AU - Panatieri,Raquel H, AU - Amorim,Kelly N S, AU - Yamamoto,Marcio M, AU - Ferreira,Luís C S, AU - Alves,Ada M B, AU - Boscardin,Silvia B, Y1 - 2013/07/18/ PY - 2012/11/22/received PY - 2013/06/12/accepted PY - 2013/7/23/entrez PY - 2013/7/23/pubmed PY - 2014/2/8/medline SP - e2330 EP - e2330 JF - PLoS neglected tropical diseases JO - PLoS Negl Trop Dis VL - 7 IS - 7 N2 - Dengue is the most prevalent arboviral infection, affecting millions of people every year. Attempts to control such infection are being made, and the development of a vaccine is a World Health Organization priority. Among the proteins being tested as vaccine candidates in preclinical settings is the non-structural protein 1 (NS1). In the present study, we tested the immune responses generated by targeting the NS1 protein to two different dendritic cell populations. Dendritic cells (DCs) are important antigen presenting cells, and targeting proteins to maturing DCs has proved to be an efficient means of immunization. Antigen targeting is accomplished by the use of a monoclonal antibody (mAb) directed against a DC cell surface receptor fused to the protein of interest. We used two mAbs (αDEC205 and αDCIR2) to target two distinct DC populations, expressing either DEC205 or DCIR2 endocytic receptors, respectively, in mice. The fusion mAbs were successfully produced, bound to their respective receptors, and were used to immunize BALB/c mice in the presence of polyriboinosinic: polyribocytidylic acid (poly (I:C)), as a DC maturation stimulus. We observed induction of strong anti-NS1 antibody responses and similar antigen binding affinity irrespectively of the DC population targeted. Nevertheless, the IgG1/IgG2a ratios were different between mouse groups immunized with αDEC-NS1 and αDCIR2-NS1 mAbs. When we tested the induction of cellular immune responses, the number of IFN-γ producing cells was higher in αDEC-NS1 immunized animals. In addition, mice immunized with the αDEC-NS1 mAb were significantly protected from a lethal intracranial challenge with the DENV2 NGC strain when compared to mice immunized with αDCIR2-NS1 mAb. Protection was partially mediated by CD4(+) and CD8(+) T cells as depletion of these populations reduced both survival and morbidity signs. We conclude that targeting the NS1 protein to the DEC205(+) DC population with poly (I:C) opens perspectives for dengue vaccine development. SN - 1935-2735 UR - https://www.unboundmedicine.com/medline/citation/23875054/Targeting_the_non_structural_protein_1_from_dengue_virus_to_a_dendritic_cell_population_confers_protective_immunity_to_lethal_virus_challenge_ L2 - https://dx.plos.org/10.1371/journal.pntd.0002330 DB - PRIME DP - Unbound Medicine ER -